ACOG (Alpha Cognition) 3-1 Month Momentum %: -7.70% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $8.30
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition 3-1 Month Momentum %?

Alpha Cognition ACOG +2.98% 32 3-1 Month Momentum % is -7.70% as of Jul. 15, 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,389 Biotechnology companies, Alpha Cognition ranks better than 57.52% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-15), Alpha Cognition's 3-1 Month Momentum % is -7.70%.

The industry rank for Alpha Cognition's 3-1 Month Momentum % or its related term are showing as below:

ACOG's 3-1 Month Momentum % is ranked better than
57.52% of 1389 companies
in the Biotechnology industry
Industry Median: -11.45 vs ACOG: -7.70

Alpha Cognition  (NAS:ACOG) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Alpha Cognition 3-1 Month Momentum % Related Terms

ACOG vs HURA, MENS, ENLV: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, Alpha Cognition's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's 3-1 Month Momentum % falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition  (NAS:ACOG) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -7.70% mean?
Alpha Cognition (ACOG) has a 3-1 Month Momentum % of -7.70% as of Jul. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Alpha Cognition and its competitors. According to the industry distribution chart, Alpha Cognition ranks #590 out of 1389 companies in the Biotechnology industry, placing it in the top 42.5%.
Is Alpha Cognition's 3-1 Month Momentum % too high?
Alpha Cognition's current 3-1 Month Momentum % is -7.70%. Based on the distribution chart, Alpha Cognition ranks #590 out of 1389 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's 3-1 Month Momentum % compare to HURA and MENS?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #590 out of 1389 companies for 3-1 Month Momentum %. This puts Alpha Cognition in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Alpha Cognition and its competitors. Alpha Cognition's current 3-1 Month Momentum % is -7.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current 3-1 Month Momentum % of -7.70%. The current 3-1 Month Momentum % is -7.70%. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current 3-1 Month Momentum % is -7.70% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.30
Price